Cargando…

Recurrent SPECC1L–NTRK fusions in pediatric sarcoma and brain tumors

The identification of rearrangements driving expression of neurotrophic receptor tyrosine kinase (NTRK) family kinases in tumors has become critically important because of the availability of effective, specific inhibitor drugs. Whole-genome sequencing (WGS) combined with RNA sequencing (RNA-seq) ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khuong-Quang, Dong-Anh, Brown, Lauren M., Wong, Marie, Mayoh, Chelsea, Sexton-Oates, Alexandra, Kumar, Amit, Pinese, Mark, Nagabushan, Sumanth, Lau, Loretta, Ludlow, Louise E., Gifford, Andrew J., Rodriguez, Michael, Desai, Jayesh, Fox, Stephen B., Haber, Michelle, Ziegler, David S., Hansford, Jordan R., Marshall, Glenn M., Cowley, Mark J., Ekert, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784491/ https://www.ncbi.nlm.nih.gov/pubmed/33144287 http://dx.doi.org/10.1101/mcs.a005710

Ejemplares similares

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
por: Ziegler, David S., et al.
Publicado: (2018)

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes
por: Ajuyah, Pamela, et al.
Publicado: (2023)

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Nagabushan, Sumanth, et al.
Publicado: (2021)

DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

SPECC1L Mutations Are Not Common in Sporadic Cases of Opitz G/BBB Syndrome
por: Migliore, Chiara, et al.
Publicado: (2022)

BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma
por: Fang, Shuo-Gui, et al.
Publicado: (2022)

SPECC1L-deficient primary mouse embryonic palatal mesenchyme cells show speed and directionality defects
por: Goering, Jeremy P., et al.
Publicado: (2021)

HGG-20. NOVEL PAEDIATRIC CASE OF A SPINAL HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES IN A PATIENT WITH NOONAN SYNDROME
por: Staunton, Jordan, et al.
Publicado: (2023)

Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications
por: Sullivan, Patricia J., et al.
Publicado: (2023)

SPECC1L deficiency results in increased adherens junction stability and reduced cranial neural crest cell delamination
por: Wilson, Nathan R., et al.
Publicado: (2016)

circSPECC1 Promotes Proliferation and Migration of LNCaP Prostate Cancer Cells by Affecting Their Epithelial-Mesenchymal Transition
por: Xie, Fangmei, et al.
Publicado: (2023)

GCT-20. Multi-Institutional Analysis of Pediatric Relapsed/Refractory Central Nervous System Germ Cell Tumors
por: Nagabushan, Sumanth, et al.
Publicado: (2022)

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
por: O’Haire, Sophie, et al.
Publicado: (2023)

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
por: Terry, Rachael L., et al.
Publicado: (2021)

Expression of the neurotrophic tyrosine kinase receptors, ntrk1 and ntrk2a, precedes expression of other ntrk genes in embryonic zebrafish
por: Hahn, Katie, et al.
Publicado: (2020)

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018)

Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach
por: Yeo, Kee Kiat, et al.
Publicado: (2022)

RARE-15. EARLY PSEUDOPROGRESSION POST-RADIATION IN PAEDIATRIC HIGH-GRADE GLIOMA PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY: TWO CASE REPORTS FROM A SINGLE CENTRE
por: Teng, Ay-Jiuan, et al.
Publicado: (2020)

A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes
por: Hanson, Derek, et al.
Publicado: (2020)

Circ‐SPECC1 modulates TGFβ2 and autophagy under oxidative stress by sponging miR‐33a to promote hepatocellular carcinoma tumorigenesis
por: Zhang, Bin, et al.
Publicado: (2020)

SPECC1L binds the myosin phosphatase complex MYPT1/PP1β and can regulate its distribution between microtubules and filamentous actin
por: Mehta, Virja, et al.
Publicado: (2023)

Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
por: Daly, Rebecca, et al.
Publicado: (2023)

DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2020)

RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2021)

In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
por: Lau, Loretta M S, et al.
Publicado: (2021)

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions
por: Brčić, Iva, et al.
Publicado: (2020)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019)

NTRK fusion in Japanese colorectal adenocarcinomas
por: Yamashiro, Yuya, et al.
Publicado: (2021)

NTRK insights: best practices for pathologists
por: Hechtman, Jaclyn F.
Publicado: (2021)

A review of NTRK fusions in cancer
por: Manea, Cristina Alexandra, et al.
Publicado: (2022)

Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors
por: Konicek, Bruce W., et al.
Publicado: (2018)

Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
por: Subhash, Vinod Vijay, et al.
Publicado: (2021)

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

PATH-09. SJMB12 CLINICAL TRIAL: DISCREPANCY BETWEEN LOCAL AND CENTRAL PATHOLOGY IN ASSESSING ANAPLASTIC MEDULLOBLASTOMA – REPORT FROM A SINGLE SITE EXPERIENCE
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Correction: NTRK1 Fusion in Glioblastoma Multiforme
Publicado: (2014)

NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021)

LGG-11. COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE ‘BENIGN TUMOR’ PERCEPTION
por: Nagabushan, Sumanth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3arli6j51ks8pri82h8oog9sea